Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus Godex versus metformin alone in patients with NAFLD and type 2 diabetes or impaired glucose tolerance
KCT0000193Phase 4Completed
- Sponsor
- Celltrion Pharm
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin, Godex in metabolic dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes mellitus (T2DM), prediabetes, sponsored by Celltrion Pharm. Started May 2010; status: completed.
02
Drugs
metforminGodex
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)type 2 diabetes mellitus (T2DM)prediabetes
Beyond the preview
Go deeper on KCT0000193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000193.